A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia

被引:0
|
作者
Abousheishaa, Aya Ahmed [1 ]
Sue-Yin, Low [2 ]
Khin, Kok Chee [3 ]
Sulaiman, Ahmad Hatim [1 ]
Huri, Hasniza Zaman [4 ]
Guan, Ng Chong [1 ]
机构
[1] Univ Malaya, Dept Psychol Med, Fac Med, Kuala Lumpur, Malaysia
[2] HELP Univ, Fac Behav Sci, Dept Psychol, Kuala Lumpur, Malaysia
[3] Univ Malaya, Dept Pharm, Med Ctr, Kuala Lumpur, Malaysia
[4] Univ Malaya, Fac Pharm, Kuala Lumpur, Malaysia
关键词
Major depressive disorder; clinical practice guidelines; evidence-based practice; RECOMMENDATIONS; ADAPTATION; ADHERENCE; MOOD;
D O I
10.9734/JPRI/2021/v33i45B32821
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Clinical Practice Guidelines (CPGs) are systematically developed statements to assist practitioners and patients with appropriate health care for specific clinical circumstances. However, evidence suggests that the uptake of these recommendations in routine care is still limited, particularly in resource-constrained countries. Objectives: This article aimed to (1) identify current CPGs for the pharmacological management of MDD that address and are compatible with the needs of Malaysian psychiatrists (2) collate and summarise these CPG recommendations to produce a more culturally sensitive and end-user friendly guideline summary. Materials and Methods: A multidisciplinary steering group followed an adapted development approach that included; (1) searching for guidelines on the pharmacological management of adults with depression, (2) screening them for relevant recommendations, (3) critical appraising these guidelines, and (4) extracting the required information. A panel of experts then reviewed the developed guideline summary. Results: Six potentially relevant guidelines for the pharmacological management of depression in adults were identified. The developed summary included a decision algorithm to guide the selection of antidepressant therapy based on clinical factors, potential drug-drug interaction, tolerability, and cost of the medications. The review panel considered the summary recommendations easy to use and had the potential for uptake by busy psychiatrists. Conclusion: A CPG summary for the pharmacological management of depression was developed that focuses on evidence-based, contextually relevant recommendations that are feasible for implementation within the local healthcare settings in Malaysia. Practical Implications: The developed guideline summary has the potential to enhance the implementation of evidence-based practice in the management of Major Depressive Disorder within the Malaysian context.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 50 条
  • [1] Clinical Practice Guideline on Acupuncture and Moxibustion: Adult Major Depressive Disorder (Mild-Moderate Degree) : Determination of clinical questions
    Tang, Han
    Fan, Qi
    Guo, Li-hua
    Zhang, Yu-qing
    Feng, Yi-xuan
    Xu, Yu-qing
    Kuang, Hong-jun
    Yang, Yun-hong
    Gou, Yi
    Zhao, Hong
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2024, 34 (03) : 246 - 251
  • [2] The Management of Major Depressive Disorder: Synopsis of the 2022 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline
    McQuaid, John R.
    Buelt, Andrew
    Capaldi, Vincent
    Fuller, Matthew
    Issa, Fuad
    Lang, Adam Edward
    Hoge, Charles
    Oslin, David W.
    Sall, James
    Wiechers, Ilse R.
    Williams, Scott
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (10) : 1440 - +
  • [3] Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelines
    Simons, Peter
    Cosgrove, Lisa
    Shaughnessy, Allen F.
    Bursztajn, Harold
    INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2017, 55 : 64 - 71
  • [4] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
    Kennedy, Sidney H.
    Lam, Raymond W.
    McIntyre, Roger S.
    Tourjman, S. Valerie
    Bhat, Venkat
    Blier, Pierre
    Hasnain, Mehrul
    Jollant, Fabrice
    Levitt, Anthony J.
    MacQueen, Glenda M.
    McInerney, Shane J.
    McIntosh, Diane
    Milev, Roumen V.
    Mueller, Daniel J.
    Parikh, Sagar V.
    Pearson, Norma L.
    Ravindran, Arun V.
    Uher, Rudolf
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09): : 540 - 560
  • [5] Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
    Zhu, Yuncheng
    Wu, Zhiguo
    Zhao, Dongmei
    Wu, Xiaohui
    He, Ruoqiao
    Wang, Zuowei
    Peng, Daihui
    Fang, Yiru
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 829 - 839
  • [6] ASSESSMENT AND MANAGEMENT OF MAJOR DEPRESSIVE DISORDER IN OLDER ADULTS
    Lackamp, Jeanne
    Schlachet, Rebecca
    Sajatovic, Martha
    PSYCHIATRIA DANUBINA, 2016, 28 : S95 - S98
  • [7] Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder
    McClintock, Shawn M.
    Minto, Lex
    Denney, David A.
    Bailey, K. Chase
    Cullum, C. Munro
    Dotson, Vonetta M.
    CURRENT PSYCHIATRY REPORTS, 2021, 23 (09)
  • [8] Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder
    Shawn M. McClintock
    Lex Minto
    David A. Denney
    K. Chase Bailey
    C. Munro Cullum
    Vonetta M. Dotson
    Current Psychiatry Reports, 2021, 23
  • [9] Nutritional considerations in major depressive disorder: current evidence and functional testing for clinical practice
    Khiroya, Kathryn
    Sekyere, Eric
    McEwen, Bradley
    Bayes, Jessica
    NUTRITION RESEARCH REVIEWS, 2023,
  • [10] EscitalopramA Review of its Use in the Management of Major Depressive Disorder in Adults
    Karly P. Garnock-Jones
    Paul L. McCormack
    CNS Drugs, 2010, 24 : 769 - 796